Results 111 to 120 of about 35,271 (262)

NiV VLP-induced syncytia in 293 cells is blocked by prior treatment with NiV-specific antibody. [PDF]

open access: yes, 2013
NiV VLPs were pre-incubated for one hour at 37°C with either NiV specific antibody or Junin virus-(JV) specific antibody, or with OPTI-MEM I medium only (untreated VLPs) before inoculating onto 293 cell monolayers grown overnight in 60 mm dishes.
Linfa Wang (184291)   +4 more
core   +1 more source

One Health Insights From Pteropus medius: Nipah Virus Spillover, Microbiota, and Antimicrobial Resistance

open access: yesMicrobiologyOpen, Volume 15, Issue 4, August 2026.
Environmental and anthropogenic drivers of antibiotic resistance dissemination. The cycle reinforces how anthropogenic inputs, such as sewage, animal dung, hospital effluent, and agricultural runoff bring resistant bacteria and antibiotic residues into soil and water.
Punam Chowdhury   +3 more
wiley   +1 more source

An attachment glycoprotein nanoparticle elicits broadly neutralizing antibodies and protects against lethal Nipah virus infection

open access: yesnpj Vaccines
Nipah virus (NiV) is a zoonotic emergent paramyxovirus that can cause severe encephalitis and respiratory infections in humans, with a high fatality rate ranging from 40% to 75%.
Dan Zhou   +14 more
doaj   +1 more source

NiV Spillover Paper [PDF]

open access: yes, 2015
3 Figures and R code for NiV spillover paper in the journal, Transactions of the Royal Society of Tropical Medicine and ...
Michael Walsh (512279)
core   +1 more source

Engineering selective amyloid precursor protein inhibitors by machine learning and deep mutational scanning

open access: yesProtein Science, Volume 35, Issue 8, August 2026.
Abstract Deep mutational scanning (DMS) has proven effective for mapping protein–protein interactions (PPIs), but it cannot provide complete coverage of the mutation landscape, particularly for multi‐mutant variants. To address this limitation, we trained machine‐learning (ML) models on previously generated DMS data for a stabilized amyloid precursor ...
Reut Meiri   +5 more
wiley   +1 more source

NIV in MND/ALS [PDF]

open access: yes, 2014
Theoretical thesis.Spine title: NIV in MND/ALS.Bibliography: pages 79-82.Chapter 1. Introduction -- Chapter 2. Literature review -- Chapter 3. Methodology -- Chapter 4. Results -- Chapter 5. Discussion -- Chapter 6.
Chow, Wai Kuen
core  

Supporting MND Patients Using NIV: Experiences of professional caregivers [PDF]

open access: yes, 2017
Background Regular administration of positive pressure non-invasive ventilation (NIV), typically at night to ameliorate nocturnal hypoventilation, extends survival without halting disease progression (1).
Cousins, Rosanna   +2 more
core   +1 more source

Respiratory Support in the Emergency Department: An Updated Systematic Review and Meta‐Analysis

open access: yesWorldviews on Evidence-Based Nursing, Volume 23, Issue 4, August 2026.
ABSTRACT Background An estimated 20% of emergency department (ED) patients require respiratory support (RS). Evidence suggests that nasal high flow (NHF) reduces RS need. Aims This is an update of a published review comparing NHF to non‐invasive ventilation (NIV) or to conventional oxygen therapy (COT) in adult ED patients.
Jane O'Donnell, Rebecca Fenn
wiley   +1 more source

Comparison between high-flow nasal oxygen (HFNO) alternated with non-invasive ventilation (NIV) and HFNO and NIV alone in patients with COVID-19: a retrospective cohort study

open access: yesEuropean Journal of Medical Research
Background Non-invasive respiratory support (conventional oxygen therapy [COT], non-invasive ventilation [NIV], high-flow nasal oxygen [HFNO], and NIV alternated with HFNO [NIV + HFNO] may reduce the need for invasive mechanical ventilation (IMV) in ...
Amanda Pereira da Cruz   +11 more
doaj   +1 more source

Co‐Detoxification of Multiple Mycotoxins: Microbial and Enzymatic Biodegradation Processes

open access: yesFood Frontiers, Volume 7, Issue 4, July 2026.
The presence of mycotoxins poses a threat to food safety. This article reviews microbial/enzymatic detoxification technologies and the main degradation pathways of key mycotoxins. We propose to overcome current bottlenecks through enzyme engineering and synthetic biology, providing a roadmap for sustainable and scalable solutions.
Lixia Fan   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy